Filing Flows

Filing Flows › Companies › Shoulder Innovations › Cash flow

Shoulder Innovations cash flow, quarter by quarter

Latest: Q3 2026 · from the cash-flow statements filed with the SEC

Free cash flow−$7.0M in Q3 2026 · −$42.7M over twelve months

Operating cash flow−$6.4M
Capital spending−$586K
Free cash flow−$7.0M
Cash conversion cycle543 days

Analysis

In Q3 2026, Shoulder Innovations generated −$6.4M of operating cash flow and spent $586K on capital projects, leaving free cash flow of −$7.0M. That is $4.4M more than in Q3 2025 (−$11.4M).

Over the twelve months to Sep 30, 2026, operating cash flow was −$34.9M; the largest uses were operating cash flow ($34.9M), capital spending ($7.8M), shares issued ($1.3M); besides operations, cash came from other investing ($25.9M); the cash balance fell by $18.5M.

Operating cash flow was −$6.4M against net income of −$7.0M. The largest differences: receivables +$1.5M, inventory −$1.5M, payables −$1.2M.

Its cash conversion cycle was 543 days (receivables 57 + inventory 624 − payables 138).

Free cash flow

Shoulder Innovations: free cash flow by quarterShoulder Innovations: free cash flow by quarter−$4.3MQ4 2024−$7.3MQ1 2025−$6.3MQ2 2025−$11.4MQ3 2025−$11.1MQ4 2025−$15.1MQ1 2026−$9.5MQ2 2026−$7.0MQ3 2026
Operating cash flow less capital spending.
Shoulder Innovations: operating cash flow against capital spendingShoulder Innovations: operating cash flow against capital spendingOperating cash flowCapital spending−$3.3M$1.0MQ4 2024−$6.5M$843KQ1 2025−$4.8M$1.5MQ2 2025−$8.6M$2.8MQ3 2025−$8.8M$2.3MQ4 2025−$12.4M$2.7MQ1 2026−$7.4M$2.2MQ2 2026−$6.4M$586KQ3 2026
Latest (Q3 2026): Operating cash flow −$6.4M, Capital spending $586K.

Cash runway and the debt wall

Cash & investments$92.3M
Debt$14.8M
Net cash$77.5M
Cash runway2.2 years

Shoulder Innovations is burning cash: its operations consume cash, a free cash flow of −$42.7M a year at the current rate against $92.3M of cash and investments: a runway of about 2.2 years before any new financing.

Where the cash came from and went

Shoulder Innovations: sources (+) and uses (−) of cash, Q3 2026Shoulder Innovations: sources (+) and uses (−) of cash, Q3 2026Other investing$18.7MCash drawn (+) / kept (−)−$12.0MOperating cash flow−$6.4MCapital spending−$586KShares issued$215K
Shoulder Innovations: sources (+) and uses (−) of cash, TTM to Q3 2026Shoulder Innovations: sources (+) and uses (−) of cash, TTM to Q3 2026Operating cash flow−$34.9MOther investing$25.9MCash drawn (+) / kept (−)$18.5MCapital spending−$7.8MShares issued−$1.3MOther financing−$507K

From profit to cash

Shoulder Innovations: net income to operating cash flow, Q3 2026Shoulder Innovations: net income to operating cash flow, Q3 2026Net income−$7.0MDepreciation & amortization$1.1MStock-based pay$1.0MOther non-cash$101KReceivables$1.5MInventory−$1.5MPayables−$1.2MPrepaid and other assets−$261KOperating cash flow−$6.4M
Non-cash charges are added back; money tied up in receivables or inventory is subtracted.
QuarterReceivable daysInventory daysPayable daysCash conversion cycle
Q3 202657624138543
Q2 202657545144458
Q1 202651525179397
Q4 202549561243367
Q3 202555600246409

Every quarter

QuarterOperating cash flowCapital spendingShares issuedCash drawn (+) / kept (−)Free cash flow
Q3 2026−$6.4M−$586K$215K−$12.0M−$7.0M
Q2 2026−$7.4M−$2.2M$423K−$13.0M−$9.5M
Q1 2026−$12.4M−$2.7M$101K$15.4M−$15.1M
Q4 2025−$8.8M−$2.3M−$2.0M$28.1M−$11.1M
Q3 2025−$8.6M−$2.8M$492K−$27.9M−$11.4M
Q2 2025−$4.8M−$1.5M$20.0M−$20.7M−$6.3M
Q1 2025−$6.5M−$843K$19.7M−$247K−$7.3M
Q4 2024−$3.3M−$1.0M—−$378K−$4.3M

Shoulder Innovations: income statement and cash flow

Shoulder Innovations, Q3 2026: revenue $16.2M (+38% year over year), operating margin -46.9%. The chart follows the revenue to costs, profit and cash.

Shoulder Innovations: every quarter, Q/Q and Y/Y → Open in the app

Read automatically from the company’s XBRL cash-flow statements; quarterly figures for the fourth quarter are the year less the first three. Errors are possible. Not investment advice.